Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

ResMed Inc. (RMD) Balance Sheet

As of 2026-06-30 (10-K), ResMed Inc. (RMD) reported total assets of $9.0B, total liabilities of $2.4B and shareholders' equity of $6.6B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $1.5B. Long-term debt: $399.4M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RMDResMed Inc.Follow RMD — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
36.5B
P/E TTM
24.2
Dividend yield
0.9%
52-week
—
Next earnings
29 Oct, in 5 days
LineFY2011
Jun 11
FY2012
Jun 12
FY2013
Jun 13
FY2014
Jun 14
FY2015
Jun 15
FY2016
Jun 16
FY2017
Jun 17
FY2018
Jun 18
FY2019
Jun 19
FY2020
Jun 20
FY2021
Jun 21
FY2022
Jun 22
FY2023
Jun 23
FY2024
Jun 24
FY2025
Jun 25
FY2026
Jun 26
Latest
Jun 26
Trend
Cash and equivalents0.740.810.880.910.720.730.820.190.150.460.300.270.230.241.211.471.47
Receivables0.270.280.320.360.360.380.450.480.530.470.610.580.700.840.941.041.04
Inventory0.200.170.150.170.250.220.270.270.350.420.460.741.000.820.930.950.95
Current assets1.291.361.451.561.411.421.641.071.151.521.571.932.372.363.514.324.32
Total assets2.072.142.212.362.183.263.473.064.114.594.735.106.756.878.178.978.97
Current liabilities0.210.250.570.270.270.640.360.510.560.600.910.690.760.911.021.401.40
Long-term debt0.100.250.300.300.301.171.080.271.261.160.640.771.430.700.660.400.40
Short-term debt0.000.000.300.00—0.30—0.010.010.010.010.010.010.010.010.260.26
Total liabilities0.340.530.600.600.591.561.511.002.042.091.841.742.622.012.212.382.38
Shareholders' equity1.731.611.611.761.591.691.962.062.072.502.893.364.134.865.976.596.59

USD billions · SEC XBRL

ResMed Inc. — questions

How much cash does ResMed Inc. have?
$1.5B in cash and cash equivalents as of 2026-06-30.
How much debt does ResMed Inc. have?
$399.4M of long-term debt and $259.9M due within a year as of 2026-06-30.
What are ResMed Inc.'s total assets?
$9.0B as of 2026-06-30.
What is ResMed Inc.'s shareholders' equity?
$6.6B as of 2026-06-30.

Every figure on this page comes from ResMed Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.